Skip to content
Screener

Cardiol Therapeutics CRDL Q4 2025 earnings

Reported March 30, 2026 · Before market open

EPS-$0.05Beat by $0.04
EPS estimate-$0.09

Next report

Date not yet announced

FAQ

When did Cardiol Therapeutics report Q4 2025 earnings?
Cardiol Therapeutics (CRDL) reported Q4 2025 earnings on March 30, 2026 before market open.
What were Cardiol Therapeutics's Q4 2025 revenue and EPS?
Cardiol Therapeutics reported eps of $-0.05 for Q4 2025.
Did Cardiol Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.09 by $0.04.
How did Cardiol Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 27.2% from $-0.07.